SCOPUS 정보 검색 플랫폼

Clinical Cancer Research

Volumn 6, Issue 10, 2000, Pages 3885-3894

A Phase I and pharmacologic evaluation of the DNA intercalator CI-958 in patients with advanced solid tumors

(6) Dees, E Claire a Whitfield, Lloyd R b Grove, William R b Rummel, Sue b Grochow, Louise B a Donehower, Ross C a

a JOHNS HOPKINS UNIVERSITY (United States)

b PFIZER INC (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INDAZOLE DERIVATIVE; INTERCALATING AGENT; LEDOXANTRONE;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; ASTHENIA; CHILL; CLINICAL ARTICLE; CLINICAL TRIAL; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG HALF LIFE; DRUG TOLERABILITY; FEMALE; HUMAN; MALE; NEPHROTOXICITY; NEUTROPENIA; PHARMACODYNAMICS; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PHLEBITIS; PRIORITY JOURNAL; SOLID TUMOR; VOMITING;

ADULT; AGED; ANTINEOPLASTIC AGENTS; AREA UNDER CURVE; DNA; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; INDAZOLES; INTERCALATING AGENTS; MALE; MAXIMUM TOLERATED DOSE; MIDDLE AGED; NEOPLASMS; TIME FACTORS;

EID: 0033765386 PISSN: 10780432 EISSN: None Source Type: Journal
DOI: None Document Type: Article

Times cited : (23)

References (18)

1
- 0001852505
- B. A. Chabner and D. L. Longo (eds.) Cancer Chemotherapy and Biotherapy. Philadelphia: Lippincott-Raven
- (1996) Anthracyclines , pp. 409-434
- Doroshow, J.H.¹

2
- 0001633968
- Characterization of drug resistance to the benzothiopyranoindazole, CI-958
- (1994) Proc. Am. Assoc. Cancer Res. , vol.35 , pp. A2019
- Steinkampf, R.N.¹ Sebolt-Leopold, J.² Klohs, W.D.³

3
- 0023836434
- Biochemical pharmacology and DNA-drug interactions by CI-958, a new antitumor intercalator derived from a series of substituted 2[H]-1-benzothiopyrano[4,3,2-cd]indazoles
- (1988) Mol. Pharmacol. , vol.33 , pp. 84-92
- Fry, D.W.¹ Besserer, J.A.²

4
- 0030749549
- Accelerated titration designs for Phase I clinical trials in oncology
- (1997) J. Natl. Cancer Inst. , vol.89 , pp. 1138-1147
- Simon, R.¹ Freidlin, B.² Rubenstein, L.³ Arbuck, S.G.⁴ Collins, J.⁵ Christian, M.C.⁶

5
- 0025148278
- Continual reassessment method: A practical design for Phase I clinical trials in cancer
- (1990) Biometrics , vol.46 , pp. 33-48
- O'Quigley, J.¹ Pepe, M.² Fisher, L.³

6
- 0022569778
- Potential roles for preclinical pharmacology in Phase I clinical trials
- (1986) Cancer Treat. Rep. , vol.70 , pp. 73-80
- Collins, J.M.¹ Zaharko, D.S.² Dedrick, R.L.³ Chabner, B.A.⁴

7
- 20644459413
- Appraisal of methods for the study of chemotherapy of cancer in man: Comparative therapeutic trial of nitrogen mustard and triethylene thiophosphoramide
- (1960) J. Chron. Dis. , vol.11 , pp. 7-33
- Zubrod, C.G.¹ Schneiderman, M.² Frei, E.³ Brindley, C.⁴ Gold, G.L.⁵

8
- 0020965053
- LAGRAN program for area and moments in pharmacokinetic analysis
- (1983) Comp. Prog. Biomed. , vol.16 , pp. 203-216
- Rocci, M.L.¹ Jusko, W.J.²

9
- 0019785890
- Understanding the dose-effect relationship: Clinical application of pharmacokinetic-pharmacodynamic models
- (1981) Clin. Pharmacokinet. , vol.6 , pp. 429-453
- Holford, N.H.G.¹ Sheiner, L.B.²

10
- 0032712261
- A Phase II trial of CI-958 in patients with hormone-refractory prostate cancer
- (1999) Cancer Chemother. Pharmacol. , vol.44 , pp. 511-517
- Woolley, P.V.¹ Freiha, F.S.² Smith, D.C.³ Carlson, L.⁴ Hofacker, J.⁵ Quinn, N.⁶ Grove, W.⁷ Trump, D.L.⁸

11
- 0032948092
- Phase II study of CI-958 in colorectal cancer
- (1999) Cancer Chemother. Pharmacol. , vol.43 , pp. 162-164
- Shields, A.F.¹ Philip, P.A.² LoRusso, P.M.³ Ferris, A.M.⁴ Zalupski, M.M.⁵

12
- 0023184783
- Pharmacokinetically guided dose escalation in Phase I clinical trials. Commentary and proposed guidelines
- (1987) Eur. J. Cancer Clin. Oncol. , vol.23 , pp. 1083-1087

13
- 0029114553
- Interspecies differences in the kinetic properties of deoxycytidine kinase elucidate the poor utility of a Phase I pharmacologically directed dose-escalation concept for 2-chloro-2-deoxyadenosine
- (1995) Cancer Chemother. Pharmacol. , vol.36 , pp. 524-529
- Reichelova, V.¹ Juliusson, G.² Spasokoukotskaja, T.³ Eriksson, S.⁴ Liliemark, J.⁵

14
- 0025236690
- Pharmacology and clinical toxicity of 4'-iodo-4'-deoxydoxorubicin: An example of successful application of pharmacokinetics to dose escalation in Phase I trials
- (1990) J. Natl. Cancer Inst. , vol.82 , pp. 469-477
- Gianni, L.¹ Vigano, L.² Surbone, A.³ Ballinari, D.⁴ Casali, P.⁵ Tarella, C.⁶ Collins, J.M.⁷ Bonadonna, G.⁸

15
- 0026575471
- Clinical pharmacokinetics of the anthrapyrazole CI-941: Factors compromising the implementation of a pharmacokinetically guided dose escalation scheme
- (1992) Cancer Res. , vol.52 , pp. 603-609
- Graham, M.A.¹ Newell, D.R.² Foster, B.J.³ Gumbrell, L.A.⁴ Jenns, K.E.⁵ Calvert, A.H.⁶

16
- 0025291805
- Phase I study and pharmacodynamics of piraxantrone (NSC 349174), a new anthrapyrazole
- (1990) Cancer Res. , vol.50 , pp. 3284-3288
- Hantel, A.¹ Donehower, R.C.² Rowinsky, E.K.³ Vance, E.⁴ Clarke, B.V.⁵ McGuire, W.P.⁶ Ettinger, D.S.⁷ Noe, D.A.⁸ Grochow, L.B.⁹

17
- 0025277042
- Phase I and clinical pharmacological evaluation of pirazatrone hydrochloride (oxantrazole)
- (1990) Cancer Res. , vol.50 , pp. 3905-3909
- Ames, M.M.¹ Loprinzi, C.L.² Collins, J.C.³ Van Haelst-Pisani, C.⁴ Richardson, R.L.⁵ Ribin, J.⁶ Moertel, C.G.⁷

18
- 85008512784
- Pharmacologically guided dose escalation of CI-958 in phase I clinical testing
- (1992) Proc. Am. Assoc. Cancer Res. , vol.33 , pp. 3162a
- Whitfield, L.R.¹ Grove, W.² Kowal, C.³ Rowinsky, E.K.⁴ Grochow, L.B.⁵ Donehower, R.C.⁶

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.